Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.475
-0.065 (-4.22%)
At close: Apr 28, 2026, 4:00 PM EDT
1.560
+0.085 (5.76%)
After-hours: Apr 28, 2026, 7:28 PM EDT
CMMB's stock price has decreased by -71.85% in the past year and price targets may not have had time to catch up.

Chemomab Therapeutics Analyst Ratings

Total Analysts
1
Consensus Rating
Buy
Price Target
$25.00
Upside
+1,594.92%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Buy
Maintains
$10$25
Buy Maintains $10$25 +1,594.92% Aug 27, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$44$40
Buy Maintains $44$40 +2,611.86% May 16, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$16$28
Strong Buy Maintains $16$28 +1,798.31% Feb 20, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$52$44
Buy Reiterates $52$44 +2,883.05% Nov 15, 2024
Maxim Group
Maxim Group
Strong Buy
Initiates
$16
Strong Buy Initiates $16 +984.75% May 13, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$24
Buy Upgrades $24 +1,527.12% May 6, 2024
Oppenheimer
Oppenheimer
Hold
Maintains
n/a
Hold Maintains n/a n/a Mar 8, 2024
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong Buy Initiates $28 +1,798.31% Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong Buy Initiates $28 +1,798.31% Oct 6, 2023
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 7, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$48$28
Buy Maintains $48$28 +1,798.31% Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$120$80
Buy Maintains $120$80 +5,323.73% Mar 10, 2022
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$120
Strong Buy Initiates $120 +8,035.59% Dec 7, 2021
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$180
Buy Initiates $180 +12,103.39% May 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$168
Buy Initiates $168 +11,289.83% May 7, 2021